Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese

[1]  J. Herbert,et al.  Fracture history and bone loss in patients with MS , 1998, Neurology.

[2]  J. Kira,et al.  HLA-DP-associated susceptibility to the optico-spinal form of multiple sclerosis in the Japanese. , 1998, Tissue antigens.

[3]  F. Weber,et al.  Synergistic immunomodulatory effects of interferon‐β1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing‐remitting multiple sclerosis , 1998, Annals of neurology.

[4]  S. Kikuchi,et al.  The significance of oligoclonal bands in multiple sclerosis in Japan: Relevance of immunogenetic backgrounds , 1998, Journal of the Neurological Sciences.

[5]  H. Link,et al.  Immune regulation within the central nervous system , 1998, Journal of the Neurological Sciences.

[6]  M. Jensen,et al.  All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis. , 1998, Archives of neurology.

[7]  M. Cippitelli,et al.  Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. , 1998, The Journal of clinical investigation.

[8]  K. Miyasaka,et al.  Anti-nuclear antibodies and the optic-spinal form of multiple sclerosis , 1997, Journal of Neurology.

[9]  Shozo Tobimatsu,et al.  Western versus asian types of multiple sclerosis: Immunogenetically and clinically distinct disorders , 1996, Annals of neurology.

[10]  S. Kikuchi,et al.  Antineutrophil cytoplasmic antibodies and the optic-spinal form of multiple sclerosis in Japan. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[11]  P. Goodfellow,et al.  A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 , 1996, Nature Genetics.

[12]  J. Haines,et al.  A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex , 1996, Nature Genetics.

[13]  D. Hinds,et al.  A full genome search in multiple sclerosis , 1996, Nature Genetics.

[14]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. McKinnon,et al.  Regulation of Oligodendrocyte Development and CNS Myelination by Growth Factors: Prospects for Therapy of Demyelinating Disease , 1996, Brain pathology.

[16]  R. Evans,et al.  The RXR heterodimers and orphan receptors , 1995, Cell.

[17]  L. Freedman,et al.  Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor , 1995, Molecular and cellular biology.

[18]  R. Bouillon,et al.  Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 α, 25-(OH)2D3 , 1995, Journal of Neuroimmunology.

[19]  L. Adorini,et al.  The role of IL-12 in the induction of organ-specific autoimmune diseases. , 1995, Immunology today.

[20]  J. Lemire.  Immunomodulatory actions of 1,25-Dihydroxyvitamin D3 , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[21]  R. Rizzoli,et al.  Vitamin D receptor genotypes and bone mineral density , 1995, The Lancet.

[22]  S. Sawcer,et al.  Genes and susceptibility to multiple sclerosis , 1995, Acta neurologica Scandinavica. Supplementum.

[23]  H. Mcdevitt,et al.  Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. , 1995, Immunology today.

[24]  J. Herbert,et al.  High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis , 1994, Neurology.

[25]  M. Thomasset.  [Vitamin D and the immune system]. , 1994, Pathologie-biologie.

[26]  J. Eisman,et al.  Prediction of bone density from vitamin D receptor alleles , 1994, Nature.

[27]  Jan Hillert,et al.  Human leukocyte antigen studies in multiple sclerosis , 1994, Annals of neurology.

[28]  T. Koike,et al.  Anticardiolipin antibodies in Japanese patients with multiple sclerosis , 1993, Acta neurologica Scandinavica.

[29]  G. Schwartz.  Hypothesis: calcitriol mediates pregnancy's protective effect on multiple sclerosis. , 1993, Archives of neurology.

[30]  K. Tashiro,et al.  HLA profiles of multiple sclerosis in Hokkaido, the northernmost island of Japan , 1992, Acta neurologica Scandinavica.

[31]  R. Bouillon,et al.  1,25-Dihydroxyvitamin D3 Prevents Insulitis in NOD Mice , 1992, Diabetes.

[32]  Kazuo Miyasaka,et al.  MRI findings of multiple sclerosis with acute transverse myelopathy , 1992, Journal of the Neurological Sciences.

[33]  K. Tashiro,et al.  Multiple sclerosis in Hokkaido, the northernmost island of Japan: prospective analyses of clinical features. , 1992, Internal medicine.

[34]  J. Lemire,et al.  1,25-Dihydroxyvitamin D3 Attenuates of Expression of Experimental Murine Lupus of MRL/1 Mice , 1992 .

[35]  G. Schwartz.  Multiple sclerosis and prostate cancer: what do their similar geographies suggest? , 1992, Neuroepidemiology.

[36]  J M Lemire,et al.  1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. , 1991, The Journal of clinical investigation.

[37]  K. Tashiro,et al.  Acute transverse myelopathy in multiple sclerosis , 1990, Journal of the Neurological Sciences.

[38]  S. Manolagas,et al.  1α,25-Dihydroxyvitamin D3 Receptor Distribution and Effects in Subpopulations of Normal Human T Lymphocytes* , 1989 .

[39]  M. Fanger,et al.  Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. , 1987, The Journal of clinical investigation.

[40]  L. Glimcher,et al.  1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. , 1984, Journal of immunology.

[41]  S. Krane,et al.  Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. , 1983, The Journal of clinical endocrinology and metabolism.

[42]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[43]  E. Acheson,et al.  SOME COMMENTS ON THE RELATIONSHIP OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS TO LATITUDE, SOLAR RADIATION, AND OTHER VARIABLES , 1960, Acta psychiatrica Scandinavica. Supplementum.